Filing Details

Accession Number:
0001213900-21-010578
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-19 16:15:59
Reporting Period:
2021-02-17
Accepted Time:
2021-02-19 16:15:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1686850 Motus Gi Holdings Inc. MOTS Surgical & Medical Instruments & Apparatus (3841) 814042793
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1723539 Mark Pomeranz C/O Motus Gi Holdings, Inc.
1301 East Broward Blvd, 3Rd Floor
Ft. Lauderdale FL 33301
President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2021-02-17 65,000 $0.00 160,857 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Stock Option (right to buy) Acquisiton 2021-02-17 65,000 $0.00 65,000 $1.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,000 2031-02-17 No 4 A Direct
Footnotes
  1. On February 17, 2021, Reporting Person was granted 65,000 Common Stock restricted stock units. The restricted stock units vest in substantially equal quarterly installments over three years commencing on February 17, 2021. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").
  2. The option award was made in accordance with the terms of the 2016 Plan. The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.